Re-examination Study for General Vaccine Use to Assess the Safety Profile of Varivax in Usual Practice.
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2013
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Chickenpox; Varicella zoster virus infections
- Focus Adverse reactions
- Sponsors Merck & Co
- 02 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jul 2012 Actual patient number is 729 according to ClinicalTrials.gov.
- 02 Jul 2012 Actual end date (May 2012) added as reported by ClinicalTrials.gov.